These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10461821)

  • 1. Phenelzine treatment of selective mutism in four prepubertal children.
    Golwyn DH; Sevlie CP
    J Child Adolesc Psychopharmacol; 1999; 9(2):109-13. PubMed ID: 10461821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenelzine treatment of elective mutism: a case report.
    Golwyn DH; Weinstock RC
    J Clin Psychiatry; 1990 Sep; 51(9):384-5. PubMed ID: 2211551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective mutism: a review of the concept and treatment.
    Berger I; Jaworowski S; Gross-Tsur V
    Isr Med Assoc J; 2002 Dec; 4(12):1135-7. PubMed ID: 12516908
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluoxetine versus phenelzine in atypical depression.
    Pande AC; Birkett M; Fechner-Bates S; Haskett RF; Greden JF
    Biol Psychiatry; 1996 Nov; 40(10):1017-20. PubMed ID: 8915561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of selective mutism: focus on selective serotonin reuptake inhibitors.
    Kaakeh Y; Stumpf JL
    Pharmacotherapy; 2008 Feb; 28(2):214-24. PubMed ID: 18225967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder.
    Jenike MA; Baer L; Minichiello WE; Rauch SL; Buttolph ML
    Am J Psychiatry; 1997 Sep; 154(9):1261-4. PubMed ID: 9286186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of medication in selective mutism: a systematic review.
    Manassis K; Oerbeck B; Overgaard KR
    Eur Child Adolesc Psychiatry; 2016 Jun; 25(6):571-8. PubMed ID: 26560144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenelzine efficacy in refractory social anxiety disorder: a case series.
    Aarre TF
    Nord J Psychiatry; 2003; 57(4):313-5. PubMed ID: 12888407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine.
    Sokolski KN; Brown BJ
    Ann Pharmacother; 2006 Mar; 40(3):567-70. PubMed ID: 16478812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine treatment of children with selective mutism: an open trial.
    Dummit ES; Klein RG; Tancer NK; Asche B; Martin J
    J Am Acad Child Adolesc Psychiatry; 1996 May; 35(5):615-21. PubMed ID: 8935208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sertraline treatment of 5 children diagnosed with selective mutism: a single-case research trial.
    Carlson JS; Kratochwill TR; Johnston HF
    J Child Adolesc Psychopharmacol; 1999; 9(4):293-306. PubMed ID: 10630460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
    Celada P; Pérez J; Alvarez E; Artigas F
    J Clin Psychopharmacol; 1992 Oct; 12(5):309-15. PubMed ID: 1282522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenelzine-induced sexual dysfunction treated with sildenafil.
    Gupta S; Masand P; Ashton AK; Berry SL
    J Sex Marital Ther; 1999; 25(2):131-5. PubMed ID: 10327382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase inhibitors.
    Lippmann S
    Am Fam Physician; 1986 Jul; 34(1):113-9. PubMed ID: 3728254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression.
    Merikangas KR; Merikangas JR
    Biol Psychiatry; 1995 Nov; 38(9):603-10. PubMed ID: 8573662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common side effects associated with monoamine oxidase inhibitors.
    Remick RA; Froese C; Keller FD
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):497-504. PubMed ID: 2748873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.
    Rabkin J; Quitkin F; Harrison W; Tricamo E; McGrath P
    J Clin Psychopharmacol; 1984 Oct; 4(5):270-8. PubMed ID: 6386898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome.
    Liebowitz MR; Heimberg RG; Schneier FR; Hope DA; Davies S; Holt CS; Goetz D; Juster HR; Lin SH; Bruch MA; Marshall RD; Klein DF
    Depress Anxiety; 1999; 10(3):89-98. PubMed ID: 10604081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study.
    Black B; Uhde TW
    J Am Acad Child Adolesc Psychiatry; 1994 Sep; 33(7):1000-6. PubMed ID: 7961338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.